Section one: Contracting authority
one.1) Name and addresses
Medicines Discovery Catapult
Block 35, Mereside, Alderley Park
Cheshire
SK10 4TG
Contact
Mr Kieran McGowan
kieran.mcgowan@md.catapult.org.uk
Telephone
+44 1625708394
Country
United Kingdom
NUTS code
UKD62 - Cheshire East
Internet address(es)
Main address
Buyer's address
one.3) Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at
Additional information can be obtained from the above-mentioned address
Tenders or requests to participate must be submitted electronically via
one.4) Type of the contracting authority
Other type
Research - Drug Discovery / Health
one.5) Main activity
Other activity
Research - Drug Discovery / Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
The Supply, Delivery, Installation, Maintenance and Support of a Laboratory Information Management System
Reference number
DN524816
two.1.2) Main CPV code
- 48814000 - Medical information systems
two.1.3) Type of contract
Supplies
two.1.4) Short description
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
The UK Lighthouse Laboratories were established across the UK in a matter of weeks to dramatically increase the number of coronavirus tests that can take place each day to support the national effort against the coronavirus pandemic.
The new Lighthouse Laboratories have been constructed through a partnership with the Department of Health, Medicines Discovery Catapult, UK Biocentre and the University of Glasgow. Their development is closely supported by both the NHS and Public Health England.
MDC is leading the Lighthouse Lab located in new dedicated labs at Bruntwood SciTech’s Alderley Park.
More information on the UK Lighthouse Lab Network is available here: https://www.lighthouselabs.org.uk/
This Invitation to Tender (ITT) has been issued by MDC for The Supply, Delivery, Installation, Maintenance and Support of a Laboratory Information Management System (LIMS) for Pathology services at the Lighthouse Laboratory Services at Alderley Park. The LIMS must be able to process a range of sample types (for details see the Specification at appendix 2) and meet the requirements of ISO15189.
It is envisaged that the Contract and implementation will commence in March 2021, however, this date may be subject to slippage. It is envisaged that the contract will run until 31st December 2021, but due to the uncertainty of the Lighthouse Lab network the Contract may be terminated before this date. MDC have the option to extend this contract for a further three (3), one (1) year periods.
Tender Submissions shall be based on the Suppliers terms and conditions which must be submitted as part of Your tender submission. The Suppliers terms and conditions are subject to the approval and acceptance of MDC. Failure of MDC and the Supplier to agree suitable terms and conditions will result in the Suppliers disqualification from the tender process.
two.1.5) Estimated total value
Value excluding VAT: £1,500,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.3) Place of performance
NUTS codes
- UK - UNITED KINGDOM
two.2.4) Description of the procurement
Medicines Discovery Catapult (MDC) is a national facility for collaborative R&D exploring and developing new approaches to the discovery and proof of well targeted medicines, diagnostics and biomarkers. Funded by Innovate UK, an agency of the UK government, MDC are an independent not-for-profit company bringing together a fragmented UK sector of industry, academia, charities, technologists, services, finance companies, SMEs and start-ups who together can turn good science into new, high value products. By sharing problems, rare expertise and assets we support the growth of this new community through a time of radical business and national change.
The UK Lighthouse Laboratories were established across the UK in a matter of weeks to dramatically increase the number of coronavirus tests that can take place each day to support the national effort against the coronavirus pandemic.
The new Lighthouse Laboratories have been constructed through a partnership with the Department of Health, Medicines Discovery Catapult, UK Biocentre and the University of Glasgow. Their development is closely supported by both the NHS and Public Health England.
MDC is leading the Lighthouse Lab located in new dedicated labs at Bruntwood SciTech’s Alderley Park.
More information on the UK Lighthouse Lab Network is available here: https://www.lighthouselabs.org.uk/
This Invitation to Tender (ITT) has been issued by MDC for The Supply, Delivery, Installation, Maintenance and Support of a Laboratory Information Management System (LIMS) for Pathology services at the Lighthouse Laboratory Services at Alderley Park. The LIMS must be able to process a range of sample types (for details see the Specification appendix 2) and meet the requirements of ISO15189.
It is envisaged that the Contract and implementation will commence in March 2021, however, this date may be subject to slippage. It is envisaged that the contract will run until 31st December 2021, but due to the uncertainty of the Lighthouse Lab network the Contract may be terminated before this date. MDC have the option to extend this contract for a further three (3), one (1) year periods.
Tender Submissions shall be based on the Suppliers terms and conditions which must be submitted as part of your tender submission. The Suppliers terms and conditions are subject to the approval and acceptance of MDC. Failure of MDC and the Supplier to agree suitable terms and conditions will result in the Suppliers disqualification from the tender process.
two.2.5) Award criteria
Price is not the only award criterion and all criteria are stated only in the procurement documents
two.2.6) Estimated value
Value excluding VAT: £1,500,000
two.2.7) Duration of the contract, framework agreement or dynamic purchasing system
End date
31 December 2024
This contract is subject to renewal
No
two.2.10) Information about variants
Variants will be accepted: No
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Open procedure
Accelerated procedure
Justification:
The Tender is being conducted under the Accelerated Procedure which means that it is a single stage process. MDC has determined that a state of urgency exits that renders impracticable the time limit laid down in the PCR. Therefore, the time limit shall be not less than 15 days from the date on which the contract notice is sent. The rationale for this decision is that the current LIMS contract is due to end in April 2021 and there is not enough time to undertake a full open procedure tendering exercise.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
four.2) Administrative information
four.2.2) Time limit for receipt of tenders or requests to participate
Date
20 February 2021
Local time
12:00pm
four.2.4) Languages in which tenders or requests to participate may be submitted
English
four.2.6) Minimum time frame during which the tenderer must maintain the tender
Duration in months: 3 (from the date stated for receipt of tender)
four.2.7) Conditions for opening of tenders
Date
20 February 2021
Local time
12:05pm
Section six. Complementary information
six.1) Information about recurrence
This is a recurrent procurement: Yes
six.4) Procedures for review
six.4.1) Review body
Medicines Discovery Catapult
Block 35, Mereside, Alderley Park
Cheshire
SK104TG
laura.hough@md.catapult.org.uk
Country
United Kingdom